| abstract |
Disclosed herein are methods of treating prostate cancer in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of (i) a glucocorticoid receptor (GR) antagonist and (ii) an antiandrogen, and (iii) a third agent, wherein the third agent is selected from one or more of an AKT inhibitor, a PI3K inhibitor, or an mTOR inhibitor. |